NSE: BAYERCROP | BSE: 506285

Mid-range Performer

Download real time

4549.20 59.30 (1.32%)

30.13% Fall from 52W High

11,479 NSE+BSE Volume

NSE 09 Feb, 2026 11:51 AM (IST)

20,445.1

Market Cap

High in industry

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Bayer Cropscience is on 11 Feb 2026 for the purpose of Quarterly Results See details

Bayer Cropscience Ltd. share price target and research reports

Name: Latest research reports of Bayer Cropscience Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Bayer Cropscience Ltd.
Rating: 4
Author: Prabhudas Lilladhar

Latest analyst research reports with target prices and PDF download for BAYERCROP, BSE:506285 Bayer Cropscience Ltd.

Search Inside the pdf :

Bayer Cropscience Ltd.

24 May 2023

4549.20

1.32%

BAYER CROPSCIENCE LT

Accumulate: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

Bayer Cropscience Ltd. is trading above its 50 day SMA of 4453.8

Bayer Cropscience Ltd.

08 Feb 2023, 12:00AM

4549.20

1.32%

BAYER CROPSCIENCE LT

Accumulate: Bayer Cropscience Ltd.

Prabhudas Lilladhar

Bayer Cropscience Ltd. is trading below its 100 day SMA of 4669.6

Bayer Cropscience Ltd.

10 Nov 2022

4549.20

1.32%

BAYER CROPSCIENCE LT

Accumulate: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

Bayer Cropscience Ltd. is trading above its 50 day SMA of 4453.8

Bayer Cropscience Ltd.

01 Aug 2022

4549.20

1.32%

Ashika - Stock Picks Bayer Cropscience Ltd. - August 2022

Buy: Bayer Cropscience Ltd.

Target

Ashika Research

Number of FII/FPI investors decreased from 214 to 203 in Dec 2025 qtr

Bayer Cropscience Ltd.

03 Jun 2022

4549.20

1.32%

BAYER CROPSCIENCE LT

Accumulate: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

Number of FII/FPI investors decreased from 214 to 203 in Dec 2025 qtr

Bayer Cropscience Ltd.

05 Mar 2021

4549.20

1.32%

Monthly Update - Fertiliser sales takes a breather in February

Accumulate: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

We maintain reduce rating (TP- Rs 676) on CRIN due to capacity constraints in NPK and likely headwinds on the raw material side starting 4Q. We are positive on Urea companies given healthy volumes and significantly lower...

Number of FII/FPI investors decreased from 214 to 203 in Dec 2025 qtr

Bayer Cropscience Ltd.

12 Feb 2021

4549.20

1.32%

Q3FY21 Result Update - Giving away the gains of hay days (1H) - Downgrade to 'Accumulate'

Accumulate: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

We downgrade BYRCS topline/EBITDA/APAT estimates by 1%/9%/9% for FY21, 1%/4%/5% for FY22 and 1%/7%/8% for FY23. We roll over to FY23 estimates and maintain Accumulate rating with revised target price of Rs 6022 (Previous TP 6090) based on 35x FY23 EPS of Rs 172. Bayer reported disappointing results. While topline was in-line with our estimates @ Rs 9.2 bn with 8% growth (PLe Rs 9.3 bn), gross margin contracted by sharp 542 bps due to lower sales of high margin corn seeds and product repositioning...

Bayer Cropscience Ltd. is trading above its 50 day SMA of 4453.8

Bayer Cropscience Ltd.

10 Nov 2020

4549.20

1.32%

Q2FY21 Result Update - Soft quarter, Downgrade to Accumulate

Accumulate: Bayer Cropscience Ltd.

Recommendation Target

Prabhudas Lilladhar

We lower BYRCS's topline, EBITDA & APAT estimates by 2%/3%/3% for FY21E, 3%/7%/6% for FY22E & 4%/5%/5% for FY23E to factor in lower topline growth and reduced gross margin expansion than earlier anticipated. We downgrade the stock to ACCUMULATE (from BUY) with revised TP of Rs 6090 (Previous 6421) based on 35x Sept'22 EPS of Rs 167. We continue to like the stock due to its lean business model, robust cash flow generation and superior return ratios of ~20-25%. BYRCS's 3% topline growth was largely...

Bayer Cropscience Ltd. is trading below its 100 day SMA of 4669.6

Bayer Cropscience Ltd.

07 Aug 2020

4549.20

1.32%

Q1FY21 Result Update - Good all-round performance - BUY

Buy: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

Bayer reported better than expected results with robust growth in both crop protection and seeds segment. Topline/EBITDA/APAT grew by 29%/61%/57% YoY. Gross margin contraction of 240 bps would have been largely due to higher sales growth of Roundup (Glyphosate) which is a low margin product for the company. Liquidation growth continues to be better than placement growth implying limited build-up of stocks at the dealer level. With robust paddy plantings and decent growth in Corn acreages, seeds segment is...

Bayer Cropscience Ltd. is trading below its 100 day SMA of 4669.6

Bayer Cropscience Ltd.

04 Jun 2020

4549.20

1.32%

Channel Check Update - Industry set for +20% growth in 1QFY21

Buy: Bayer Cropscience Ltd.

Prabhudas Lilladhar

Domestic agrochemical industry is expected to grow +20% YoY in Q1 driven by massive surge in herbicide sales, pre-buying led by robust demand expectation and ~5% price increase in generic molecules. Geographically, North India followed by South is expected to drive growth. Also, crop wise Rice will be the single largest growth driver for the industry driven by acreage expansion and shift from transplanting rice to Direct Seeded Rice (DSR). Molecules like Bispyribac Sodium (Key player PI Ind- Nominee Gold), Pyrazosulfuron (UPL- Saathi, Dhanuka- Cempa) Pendimethalin (UPL- Dost...

Number of FII/FPI investors decreased from 214 to 203 in Dec 2025 qtr

Is Bayer Cropscience Ltd. worth buying?

123 Votes:

Buy 80.49%

Sell 12.2%

Hold 7.32%